Literature DB >> 32081282

Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure.

Dennis T Ko1, Rohan Khera2, Geoffrey Lau3, Feng Qiu3, Yongfei Wang4, Peter C Austin3, Maria Koh3, Zhenqiu Lin5, Douglas S Lee6, Harindra C Wijeysundera7, Harlan M Krumholz8.   

Abstract

BACKGROUND: Readmission rates after acute myocardial infarction (AMI) and heart failure (HF) hospitalizations have decreased in the United States since the implementation of the Hospital Readmissions Reduction Program.
OBJECTIVES: This study was designed to examine the temporal trends of readmission and mortality after AMI and HF in Ontario, Canada, where reducing hospital readmissions has not had a policy incentive.
METHODS: The cohort was comprised of AMI or HF patients 65 years of age or older who had been hospitalized from 2006 to 2017. Primary outcomes were 30-day readmission and post-discharge mortality. Secondary outcomes included in-hospital mortality, 30-day mortality from admission, and in-hospital mortality or 30-day mortality post-discharge. Adjusted monthly trends for each outcome were examined over the study period.
RESULTS: Our cohorts included 152,808 AMI and 223,283 HF patients. Age- and sex-standardized AMI hospitalization rates in Ontario declined 32% from 2006 to 2017 while HF hospitalization rates declined slightly (9.1%). For AMI, risk-adjusted 30-day readmission rates declined from 17.4% in 2006 to 14.7% in 2017. All AMI risk-adjusted mortality rates also declined from 2006 to 2017 with 30-day post-discharge mortality from 5.1% to 4.4%. For HF, overall risk-adjusted 30-day readmission was largely unchanged from 2006 to 2014 at 21.9%, followed by a decline to 20.8% in 2017. Risk-adjusted 30-day post-discharge mortality declined from 7.1% in 2006 to 6.6% in 2017.
CONCLUSIONS: The patterns of outcomes in Ontario are consistent with the United States for AMI, but diverge for HF. For AMI and HF, admissions, readmissions, and mortality rates declined over this period. The reasons for the country-specific patterns for HF need further exploration.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute myocardial infarction; heart failure; mortality; readmission; trends

Year:  2020        PMID: 32081282     DOI: 10.1016/j.jacc.2019.12.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Improving clinical trial efficiency using a machine learning-based risk score to enrich study populations.

Authors:  Karola S Jering; Claudio Campagnari; Brian Claggett; Eric Adler; Liviu Klein; Faraz S Ahmad; Adriaan A Voors; Scott Solomon; Avi Yagil; Barry Greenberg
Journal:  Eur J Heart Fail       Date:  2022-05-22       Impact factor: 17.349

Review 2.  COVID-19 and Cardiovascular Disease: a Global Perspective.

Authors:  Alessandra Pina; Silvia Castelletti
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

3.  Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia.

Authors:  Carolin Torregroza; Birce Yueksel; Raphael Ruske; Martin Stroethoff; Annika Raupach; André Heinen; Markus W Hollmann; Ragnar Huhn; Katharina Feige
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

4.  The Cardiac Care Bridge randomized trial in high-risk older cardiac patients: A mixed-methods process evaluation.

Authors:  Lotte Verweij; Denise F Spoon; Michel S Terbraak; Patricia Jepma; Ron J G Peters; Wilma J M Scholte Op Reimer; Corine H M Latour; Bianca M Buurman
Journal:  J Adv Nurs       Date:  2021-02-17       Impact factor: 3.187

5.  Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in Canada.

Authors:  Dennis T Ko; Tareq Ahmed; Peter C Austin; Warren J Cantor; Paul Dorian; Michael Goldfarb; Yanyan Gong; Michelle M Graham; Jing Gu; Nathaniel M Hawkins; Thao Huynh; Karin H Humphries; Maria Koh; Yoan Lamarche; Laurie J Lambert; Patrick R Lawler; Jean-Francois Légaré; Hung Q Ly; Feng Qiu; Ata Ur Rehman Quraishi; Derek Y So; Robert C Welsh; Harindra C Wijeysundera; Graham Wong; Andrew T Yan; Yana Gurevich
Journal:  CJC Open       Date:  2021-05-01

6.  Preventive Effect Observation of Dapagliflozin on Middle and Later Ventricular Remodeling in Patients with Acute ST Segment Elevation Anterior Wall Myocardial Infarction: A Single-Center, Retrospective Cohort Study.

Authors:  Zeyan Liu; Lijun Liu; Hao Zhang; Yang Jiang; Hengtong Wang
Journal:  J Healthc Eng       Date:  2022-04-15       Impact factor: 3.822

7.  Machine learning prediction of postoperative unplanned 30-day hospital readmission in older adult.

Authors:  Linji Li; Linna Wang; Li Lu; Tao Zhu
Journal:  Front Mol Biosci       Date:  2022-08-10

8.  The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies.

Authors:  Stephanie Poon; Benjamin Leis; Laurie Lambert; Kendra MacFarlane; Kim Anderson; Claudia Blais; Catherine Demers; Justin A Ezekowitz; Nathaniel M Hawkins; Douglas S Lee; Gordon Moe; Roopinder K Sandhu; Sean A Virani; Stephen Wilton; Shelley Zieroth; Robert McKelvie
Journal:  CJC Open       Date:  2022-08-12

9.  Myocardial Infarction Complications After Surgery in Vietnam: Estimates of Incremental Cost, Readmission Risk, and Length of Hospital Stay.

Authors:  My Hanh Bui; Quynh Long Khuong; Phuoc Thang Dao; Cao Phuong Duy Le; The Anh Nguyen; Binh Giang Tran; Duc Hung Duong; Tuan Duc Duong; Tien Hung Tran; Hoang Ha Pham; Xuan Thanh Dao; Quang Cuong Le
Journal:  Front Public Health       Date:  2021-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.